BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karsan N, Goadsby PJ. Calcitonin gene-related peptide and migraine. Current Opinion in Neurology 2015;28:250-4. [DOI: 10.1097/wco.0000000000000191] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Chan KY, Labastida-Ramírez A, Ramírez-Rosas MB, Labruijere S, Garrelds IM, Danser AH, van den Maagdenberg AM, MaassenVanDenBrink A. Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice. J Cereb Blood Flow Metab 2019;39:718-29. [PMID: 28792272 DOI: 10.1177/0271678X17725673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
2 Szok D, Csáti A, Vécsei L, Tajti J. Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety. Toxins (Basel) 2015;7:2659-73. [PMID: 26193319 DOI: 10.3390/toxins7072659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lacković Z, Filipović B, Matak I, Helyes Z. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol 2016;173:279-91. [PMID: 26493010 DOI: 10.1111/bph.13366] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
4 Giamberardino MA, Affaitati G, Curto M, Negro A, Costantini R, Martelletti P. Anti-CGRP monoclonal antibodies in migraine: current perspectives. Intern Emerg Med 2016;11:1045-57. [PMID: 27339365 DOI: 10.1007/s11739-016-1489-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
5 Liang YL, Khoshouei M, Deganutti G, Glukhova A, Koole C, Peat TS, Radjainia M, Plitzko JM, Baumeister W, Miller LJ, Hay DL, Christopoulos A, Reynolds CA, Wootten D, Sexton PM. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor. Nature 2018;561:492-7. [PMID: 30209400 DOI: 10.1038/s41586-018-0535-y] [Cited by in Crossref: 130] [Cited by in F6Publishing: 103] [Article Influence: 32.5] [Reference Citation Analysis]
6 Zhou XY, Xu XM, Wu SY, Wang F, Yang YL, Li M, Wei XZ. Spatiotemporal Changes of Calcitonin Gene-Related Peptide Innervation in Spinal Fusion. Biomed Res Int 2016;2016:5872860. [PMID: 27990431 DOI: 10.1155/2016/5872860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Giamberardino MA, Affaitati G, Costantini R, Cipollone F, Martelletti P. Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab. J Pain Res 2017;10:2751-60. [PMID: 29263689 DOI: 10.2147/JPR.S128143] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 6.4] [Reference Citation Analysis]
8 Lopes DM, Denk F, McMahon SB. The Molecular Fingerprint of Dorsal Root and Trigeminal Ganglion Neurons. Front Mol Neurosci 2017;10:304. [PMID: 29018326 DOI: 10.3389/fnmol.2017.00304] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
9 Geyik S, Ergun S, Kuzudişli S, Şensoy F, Temiz E, Altunışık E, Korkmaz M, Dağlı H, Kul S, Akçalı A, Neyal AM. Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines. J Headache Pain 2016;17:36. [PMID: 27090416 DOI: 10.1186/s10194-016-0623-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Chen N, Su W, Cui SH, Guo J, Duan JC, Li HX, He L. A novel large animal model of recurrent migraine established by repeated administration of inflammatory soup into the dura mater of the rhesus monkey. Neural Regen Res 2019;14:100-6. [PMID: 30531083 DOI: 10.4103/1673-5374.243715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kamshilin AA, Volynsky MA, Khayrutdinova O, Nurkhametova D, Babayan L, Amelin AV, Mamontov OV, Giniatullin R. Novel capsaicin-induced parameters of microcirculation in migraine patients revealed by imaging photoplethysmography. J Headache Pain 2018;19:43. [PMID: 29915934 DOI: 10.1186/s10194-018-0872-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Peters GL, Hennessey EK. Rimegepant: acute treatment for migraine headaches. Pain Manag 2021;11:259-66. [PMID: 33550872 DOI: 10.2217/pmt-2020-0090] [Reference Citation Analysis]
13 Zirimwabagabo JO, Jailani ABA, Avgoustou P, Tozer MJ, Gibson KR, Glossop PA, Mills JEJ, Porter RA, Blaney P, Wang N, Skerry TM, Richards GO, Harrity JPA. Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization. J Med Chem 2021;64:3299-319. [PMID: 33666424 DOI: 10.1021/acs.jmedchem.0c02191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Aral LA, ErgÜn MA, Bolay H. Cellular iron storage and trafficking are affected by GTN stimulation in primary glial and meningeal cell culture. Turk J Biol 2021;45:46-55. [PMID: 33597821 DOI: 10.3906/biy-2009-1] [Reference Citation Analysis]
15 Liu C, Zhang Y, Liu Q, Jiang L, Li M, Wang S, Long T, He W, Kong X, Qin G, Chen L, Zhang Y, Zhou J. P2X4-receptor participates in EAAT3 regulation via BDNF-TrkB signaling in a model of trigeminal allodynia. Mol Pain 2018;14:1744806918795930. [PMID: 30146940 DOI: 10.1177/1744806918795930] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
16 Yang L, Xu M, Bhuiyan SA, Li J, Zhao J, Cohrs RJ, Susterich JT, Signorelli S, Green U, Stone JR, Levy D, Lennerz JK, Renthal W. Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine. Neuron 2022:S0896-6273(22)00228-8. [PMID: 35349784 DOI: 10.1016/j.neuron.2022.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
17 Melo-Carrillo A, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM, Burstein R. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody. J Neurosci 2017;37:7149-63. [PMID: 28642283 DOI: 10.1523/JNEUROSCI.0576-17.2017] [Cited by in Crossref: 72] [Cited by in F6Publishing: 29] [Article Influence: 14.4] [Reference Citation Analysis]
18 Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors. J Neurosci 2017;37:10587-96. [PMID: 28972120 DOI: 10.1523/JNEUROSCI.2211-17.2017] [Cited by in Crossref: 69] [Cited by in F6Publishing: 29] [Article Influence: 13.8] [Reference Citation Analysis]
19 Akerman S, Romero-Reyes M. Preclinical studies investigating the neural mechanisms involved in the co-morbidity of migraine and temporomandibular disorders: the role of CGRP. Br J Pharmacol 2020;177:5555-68. [PMID: 32929719 DOI: 10.1111/bph.15263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Qubty W, Gelfand AA. Psychological and Behavioral Issues in the Management of Migraine in Children and Adolescents. Curr Pain Headache Rep 2016;20:69. [PMID: 27896587 DOI: 10.1007/s11916-016-0597-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Moye LS, Pradhan AA. From blast to bench: A translational mini-review of posttraumatic headache. J Neurosci Res 2017;95:1347-54. [PMID: 28151589 DOI: 10.1002/jnr.24001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
22 Monteith D, Collins EC, Vandermeulen C, Van Hecken A, Raddad E, Scherer JC, Grayzel D, Schuetz TJ, de Hoon J. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers. Front Pharmacol 2017;8:740. [PMID: 29089894 DOI: 10.3389/fphar.2017.00740] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
23 Zhao J, Levy D. The CGRP receptor antagonist BIBN4096 inhibits prolonged meningeal afferent activation evoked by brief local K+ stimulation but not cortical spreading depression-induced afferent sensitization. Pain Rep 2018;3:e632. [PMID: 29430561 DOI: 10.1097/PR9.0000000000000632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
24 Chubar V, Van Leeuwen K, Bijttebier P, Van Assche E, Bosmans G, Van den Noortgate W, van Winkel R, Goossens L, Claes S. Gene-environment interaction: New insights into perceived parenting and social anxiety among adolescents. Eur Psychiatry 2020;63:e64. [PMID: 32507125 DOI: 10.1192/j.eurpsy.2020.62] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]